Empagliflozin versus Sitagliptin as add-on dual therapy in Egyptian patients with type 2 diabetes inadequately controlled with Metformin: a 12-week randomized, open-label, parallel-group trial

Category Primary study
JournalBENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES
Year 2023
This article has no abstract
Epistemonikos ID: 342641e6c9c11f4ec6781bdc4534e420c577d553
First added on: Dec 05, 2023